Short telomeres are a risk factor for idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Short telomeres are a risk factor for idiopathic pulmonary fibrosis

Published:2008-08-27 Issue:35 Volume:105 Page:13051-13056
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Alder J. K.,Chen J. J.-L.,Lancaster L.,Danoff S.,Su S.-c.,Cogan J. D.,Vulto I.,Xie M.,Qi X.,Tuder R. M.,Phillips J. A.,Lansdorp P. M.,Loyd J. E.,Armanios M. Y.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference29 articles.

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

2. Clinical and Pathologic Features of Familial Interstitial Pneumonia

3. Heterozygosity for a Surfactant Protein C Gene Mutation Associated with Usual Interstitial Pneumonitis and Cellular Nonspecific Interstitial Pneumonitis in One Kindred

4. Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis

Cited by 658 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics combined with network pharmacology reveals the protective effect of astragaloside IV on alcoholic liver disease;Phytomedicine;2024-12

2. Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report;Annals of the American Thoracic Society;2024-09

3. Interdependence between Nuclear Pore Gatekeepers and Genome Caretakers: Cues from Genome Instability Syndromes;International Journal of Molecular Sciences;2024-08-29

4. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine;American Journal of Respiratory and Critical Care Medicine;2024-08-15

5. Protective effects of E-CG-01 (3,4-lacto cycloastragenol) against bleomycin-induced lung fibrosis in C57BL/6 mice;Biomedicine & Pharmacotherapy;2024-08